Literature DB >> 32176382

Mitochondrial disease in children.

S Rahman1.   

Abstract

Mitochondrial disease presenting in childhood is characterized by clinical, biochemical and genetic complexity. Some children are affected by canonical syndromes, but the majority have nonclassical multisystemic disease presentations involving virtually any organ in the body. Each child has a unique constellation of clinical features and disease trajectory, leading to enormous challenges in diagnosis and management of these heterogeneous disorders. This review discusses the classical mitochondrial syndromes presenting most frequently in childhood and then presents an organ-based perspective including systems less frequently linked to mitochondrial disease, such as skin and hair abnormalities and immune dysfunction. An approach to diagnosis is then presented, encompassing clinical evaluation and biochemical, neuroimaging and genetic investigations, and emphasizing the problem of phenocopies. The impact of next-generation sequencing is discussed, together with the importance of functional validation of novel genetic variants never previously linked to mitochondrial disease. The review concludes with a brief discussion of currently available and emerging therapies. The field of mitochondrial medicine has made enormous strides in the last 30 years, with approaching 400 different genes across two genomes now linked to primary mitochondrial disease. However, many important questions remain unanswered, including the reasons for tissue specificity and variability of clinical presentation of individuals sharing identical gene defects, and a lack of disease-modifying therapies and biomarkers to monitor disease progression and/or response to treatment.
© 2020 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  diagnostic approach; differential diagnosis; mitochondrial genetics; next-generation sequencing; phenocopies; phenomics

Mesh:

Year:  2020        PMID: 32176382     DOI: 10.1111/joim.13054

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  28 in total

1.  Secondary manifestations of mitochondrial disorders.

Authors:  Josef Finsterer
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

2.  Cross-comparison of systemic and tissue-specific metabolomes in a mouse model of Leigh syndrome.

Authors:  Karin Terburgh; Jeremie Z Lindeque; Francois H van der Westhuizen; Roan Louw
Journal:  Metabolomics       Date:  2021-11-18       Impact factor: 4.290

Review 3.  Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Alex Lyakhovich; Luca Tiano; Marco Trifuoggi
Journal:  Cell Mol Life Sci       Date:  2021-10-31       Impact factor: 9.261

4.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

5.  Arterioectatic Spinal Angiopathy of Childhood: Clinical, Imaging, Laboratory, Histologic, and Genetic Description of a Novel CNS Vascular Pathology.

Authors:  T Abruzzo; R van den Berg; S Vadivelu; S W Hetts; M Dishop; P Cornejo; V Narayanan; K E Ramsey; C Coopwood; E G Medici-van den Herik; S D Roosendaal; M Lawton; S Bernes
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-30       Impact factor: 4.966

6.  Pathogenic SLIRP variants as a novel cause of autosomal recessive mitochondrial encephalomyopathy with complex I and IV deficiency.

Authors:  Hubert J M Smeets; Mike Gerards; Le Guo; Bob P H Engelen; Irene M G M Hemel; Irenaeus F M de Coo; Maaike Vreeburg; Suzanne C E H Sallevelt; Debby M E I Hellebrekers; Ed H Jacobs; Farah Sadeghi-Niaraki; Florence H J van Tienen
Journal:  Eur J Hum Genet       Date:  2021-08-23       Impact factor: 4.246

Review 7.  Mitochondrial DNA copy number in human disease: the more the better?

Authors:  Roberta Filograna; Mara Mennuni; David Alsina; Nils-Göran Larsson
Journal:  FEBS Lett       Date:  2020-12-25       Impact factor: 4.124

8.  Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era.

Authors:  Patrick Forny; Emma Footitt; James E Davison; Amanda Lam; Cathy E Woodward; Spyros Batzios; Sanjay Bhate; Anupam Chakrapani; Maureen Cleary; Paul Gissen; Stephanie Grunewald; Jane A Hurst; Richard Scott; Simon Heales; Thomas S Jacques; Thomas Cullup; Shamima Rahman
Journal:  Neurol Genet       Date:  2021-05-25

Review 9.  Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.

Authors:  Niccolò Candelise; Illari Salvatori; Silvia Scaricamazza; Valentina Nesci; Henri Zenuni; Alberto Ferri; Cristiana Valle
Journal:  Metabolites       Date:  2022-03-09

10.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations.

Authors:  Sneha Rath; Rohit Sharma; Rahul Gupta; Tslil Ast; Connie Chan; Timothy J Durham; Russell P Goodman; Zenon Grabarek; Mary E Haas; Wendy H W Hung; Pallavi R Joshi; Alexis A Jourdain; Sharon H Kim; Anna V Kotrys; Stephanie S Lam; Jason G McCoy; Joshua D Meisel; Maria Miranda; Apekshya Panda; Anupam Patgiri; Robert Rogers; Shayan Sadre; Hardik Shah; Owen S Skinner; Tsz-Leung To; Melissa A Walker; Hong Wang; Patrick S Ward; Jordan Wengrod; Chen-Ching Yuan; Sarah E Calvo; Vamsi K Mootha
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.